[Physiological activity of kappa-casein glycomacropeptide]
[Article in
Russian]
- PMID: 452502
Item in Clipboard
[Physiological activity of kappa-casein glycomacropeptide]
[Article in
Russian]
Vopr Med Khim.
1979 May-Jun.
Abstract
Low molecular peptide fragment [molecular weight 700-2,000] was isolated from the preparation of k-caseine glycomacropeptide using gel chromotography on Sephadex G-25 superfine. After intravenous administration the peptide inhibited gastric secretion more distinctly as compared with the initial preparation. The data obtained suggest that the inhibitory effect of glycomacropeptide was caused by fragment but not by the whole molecule.
Similar articles
-
[Heterogeneity of the kappa-casein glycomacropeptide and physiological activity of its fractions].Vopr Pitan. 1979 Sep-Oct;(5):22-6. Vopr Pitan. 1979. PMID: 516596 Russian.
-
[Effect of kappa-casein glycomacropeptide on gastrointestinal motility in dogs].Biull Eksp Biol Med. 1983 Jul;96(7):10-2. Biull Eksp Biol Med. 1983. PMID: 6871439 Russian.
-
[Glycopeptide obtained from k-casein and its effect on protein assimilation].Vopr Pitan. 1984 Mar-Apr;(2):47-50. Vopr Pitan. 1984. PMID: 6741020 Russian.
-
Biological activities of bovine glycomacropeptide.Br J Nutr. 2000 Nov;84 Suppl 1:S39-46. doi: 10.1017/s0007114500002233. Br J Nutr. 2000. PMID: 11242445 Review.
-
Peptides affecting coagulation.Br J Nutr. 2000 Nov;84 Suppl 1:S99-102. doi: 10.1017/s0007114500002312. Br J Nutr. 2000. PMID: 11242453 Review.
Cited by
-
The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome.Nutrients. 2023 Sep 15;15(18):3991. doi: 10.3390/nu15183991. Nutrients. 2023. PMID: 37764775 Free PMC article. Review.
-
Glycomacropeptide Bioactivity and Health: A Review Highlighting Action Mechanisms and Signaling Pathways.Nutrients. 2019 Mar 12;11(3):598. doi: 10.3390/nu11030598. Nutrients. 2019. PMID: 30870995 Free PMC article. Review.
-
Appetite control and gastrointestinal hormonal behavior (CCK, GLP-1, PYY 1-36) following low doses of a whey protein-rich nutraceutic.Med J Nutrition Metab. 2013;6(3):259-266. doi: 10.1007/s12349-013-0121-7. Epub 2013 Feb 5. Med J Nutrition Metab. 2013. PMID: 24319546 Free PMC article.